Europe Contract Pharmaceutical Manufacturing Market Size, Status and Forecast 2014-2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The Contract Pharmaceutical Manufacturing market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Contract Pharmaceutical Manufacturing Market Segmentations:

    By Player:

    • Recipharm

    • DPT Laboratories

    • Aesica

    • Lonza

    • Boehringer Ingelheim

    • Catalent

    • Vetter

    • Nipro Corp

    • AbbVie

    • Piramal Healthcare

    • Aenova

    • Fareva Holding

    • DPx

    • Dishman

    • NextPharma

    • Famar

    • Jubilant

    • Sopharma

    By Type:

    • Active Pharmaceutical Ingredients

    • Finished Dosage Formulations

    By End-User:

    • Big Pharma

    • Specialty/Midsize

    • Generics

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Contract Pharmaceutical Manufacturing Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Active Pharmaceutical Ingredients from 2014 to 2026

    • 1.3.2 Europe Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Finished Dosage Formulations from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Big Pharma from 2014 to 2026

    • 1.4.2 Europe Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Specialty/Midsize from 2014 to 2026

    • 1.4.3 Europe Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Generics from 2014 to 2026

    • 1.4.4 Europe Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Contract Pharmaceutical Manufacturing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Contract Pharmaceutical Manufacturing by Major Types

      • 3.4.1 Market Size and Growth Rate of Active Pharmaceutical Ingredients

      • 3.4.2 Market Size and Growth Rate of Finished Dosage Formulations

    4 Segmentation of Contract Pharmaceutical Manufacturing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Contract Pharmaceutical Manufacturing by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Big Pharma for Construction

      • 4.4.2 Market Size and Growth Rate of Specialty/Midsize for Construction

      • 4.4.3 Market Size and Growth Rate of Generics for Construction

      • 4.4.4 Market Size and Growth Rate of Others for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Contract Pharmaceutical Manufacturing Production Analysis by Top Regions

    • 5.2 Europe Contract Pharmaceutical Manufacturing Consumption Analysis by Top Regions

    • 5.3 Europe Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.3 France Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    6 Product Circulation of Contract Pharmaceutical Manufacturing Market among Top Countries

    • 6.1 Top 5 Export Countries in Contract Pharmaceutical Manufacturing Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Contract Pharmaceutical Manufacturing Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Contract Pharmaceutical Manufacturing Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Contract Pharmaceutical Manufacturing Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Contract Pharmaceutical Manufacturing Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Contract Pharmaceutical Manufacturing Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Contract Pharmaceutical Manufacturing Landscape Analysis

    • 7.1 Germany Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 7.2 Germany Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    8. UK Contract Pharmaceutical Manufacturing Landscape Analysis

    • 8.1 UK Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 8.2 UK Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    9. France Contract Pharmaceutical Manufacturing Landscape Analysis

    • 9.1 France Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 9.2 France Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    10. Italy Contract Pharmaceutical Manufacturing Landscape Analysis

    • 10.1 Italy Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 10.2 Italy Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    11. Spain Contract Pharmaceutical Manufacturing Landscape Analysis

    • 11.1 Spain Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 11.2 Spain Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    12. Poland Contract Pharmaceutical Manufacturing Landscape Analysis

    • 12.1 Poland Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 12.2 Poland Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    13. Russia Contract Pharmaceutical Manufacturing Landscape Analysis

    • 13.1 Russia Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 13.2 Russia Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    14. Switzerland Contract Pharmaceutical Manufacturing Landscape Analysis

    • 14.1 Switzerland Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 14.2 Switzerland Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    15. Turkey Contract Pharmaceutical Manufacturing Landscape Analysis

    • 15.1 Turkey Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 15.2 Turkey Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Landscape Analysis by Top Countries

      • 16.3.1 Denmark Contract Pharmaceutical Manufacturing Market Volume and Growth Rate

      • 16.3.2 Finland Contract Pharmaceutical Manufacturing Market Volume and Growth Rate

      • 16.3.3 Norway Contract Pharmaceutical Manufacturing Market Volume and Growth Rate

      • 16.3.4 Sweden Contract Pharmaceutical Manufacturing Market Volume and Growth Rate

      • 16.3.6 Iceland Contract Pharmaceutical Manufacturing Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Landscape Analysis by Top Countries

      • 17.3.1 Belgium Contract Pharmaceutical Manufacturing Market Volume and Growth Rate

      • 17.3.2 Netherlands Contract Pharmaceutical Manufacturing Market Volume and Growth Rate

      • 17.3.3 Luxembourg Contract Pharmaceutical Manufacturing Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Landscape Analysis by Top Countries

      • 18.3.1 Estonia Contract Pharmaceutical Manufacturing Market Volume and Growth Rate

      • 18.3.2 Latvia Contract Pharmaceutical Manufacturing Market Volume and Growth Rate

      • 18.3.3 Lithuania Contract Pharmaceutical Manufacturing Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Recipharm

      • 19.1.1 Recipharm Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 DPT Laboratories

      • 19.2.1 DPT Laboratories Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Aesica

      • 19.3.1 Aesica Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Lonza

      • 19.4.1 Lonza Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Boehringer Ingelheim

      • 19.5.1 Boehringer Ingelheim Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Catalent

      • 19.6.1 Catalent Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Vetter

      • 19.7.1 Vetter Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Nipro Corp

      • 19.8.1 Nipro Corp Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 AbbVie

      • 19.9.1 AbbVie Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Piramal Healthcare

      • 19.10.1 Piramal Healthcare Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Aenova

      • 19.11.1 Aenova Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Fareva Holding

      • 19.12.1 Fareva Holding Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 DPx

      • 19.13.1 DPx Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Dishman

      • 19.14.1 Dishman Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 NextPharma

      • 19.15.1 NextPharma Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Famar

      • 19.16.1 Famar Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Jubilant

      • 19.17.1 Jubilant Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Sopharma

      • 19.18.1 Sopharma Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    The List of Tables and Figures (Totals 75 Figures and 150 Tables)

    • Figure Product Picture

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Active Pharmaceutical Ingredients Market, 2015 - 2026 (USD Million)

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Finished Dosage Formulations Market, 2015 - 2026 (USD Million)

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Big Pharma from 2014 to 2026

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Specialty/Midsize from 2014 to 2026

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Generics from 2014 to 2026

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure UK Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure France Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Contract Pharmaceutical Manufacturing Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Contract Pharmaceutical Manufacturing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Contract Pharmaceutical Manufacturing

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Contract Pharmaceutical Manufacturing by Different Types from 2014 to 2026

    • Table Consumption Share of Contract Pharmaceutical Manufacturing by Different Types from 2014 to 2026

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Active Pharmaceutical Ingredients Market, 2015 - 2026 (USD Million)

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Finished Dosage Formulations Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Contract Pharmaceutical Manufacturing by Different End-Users from 2014 to 2026

    • Table Consumption Share of Contract Pharmaceutical Manufacturing by Different End-Users from 2014 to 2026

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Big Pharma from 2014 to 2026

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Specialty/Midsize from 2014 to 2026

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Generics from 2014 to 2026

    • Figure Contract Pharmaceutical Manufacturing Market Size and Growth Rate of Others from 2014 to 2026

    • Table Europe Contract Pharmaceutical Manufacturing Production by Major Regions

    • Table Europe Contract Pharmaceutical Manufacturing Production Share by Major Regions

    • Figure Europe Contract Pharmaceutical Manufacturing Production Share by Major Countries and Regions in 2014

    • Table Europe Contract Pharmaceutical Manufacturing Consumption by Major Regions

    • Table Europe Contract Pharmaceutical Manufacturing Consumption Share by Major Regions

    • Table Germany Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table UK Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table France Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table Italy Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table Spain Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table Poland Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table Russia Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table Switzerland Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table Turkey Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Contract Pharmaceutical Manufacturing Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Contract Pharmaceutical Manufacturing Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Contract Pharmaceutical Manufacturing Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Contract Pharmaceutical Manufacturing Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table Germany Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Germany Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Germany Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table UK Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table UK Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table UK Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table UK Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table France Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table France Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table France Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table France Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Italy Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table Italy Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Italy Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Italy Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Spain Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table Spain Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Spain Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Spain Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Poland Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table Poland Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Poland Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Poland Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Russia Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table Russia Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Russia Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Russia Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table Switzerland Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Switzerland Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Switzerland Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table Turkey Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Turkey Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Turkey Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Contract Pharmaceutical Manufacturing Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Contract Pharmaceutical Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Contract Pharmaceutical Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Contract Pharmaceutical Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Contract Pharmaceutical Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Contract Pharmaceutical Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Contract Pharmaceutical Manufacturing Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Contract Pharmaceutical Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Contract Pharmaceutical Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Contract Pharmaceutical Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Contract Pharmaceutical Manufacturing Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Contract Pharmaceutical Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Contract Pharmaceutical Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Contract Pharmaceutical Manufacturing Market Volume and Growth Rate from 2014 to 2026

    • Table Recipharm Profiles

    • Table Recipharm Production, Value, Price, Gross Margin 2014-2019

    • Table Recipharm Product benchmarking

    • Table Recipharm Strategic initiatives

    • Table Recipharm SWOT analysis

    • Table DPT Laboratories Profiles

    • Table DPT Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table DPT Laboratories Product benchmarking

    • Table DPT Laboratories Strategic initiatives

    • Table DPT Laboratories SWOT analysis

    • Table Aesica Profiles

    • Table Aesica Production, Value, Price, Gross Margin 2014-2019

    • Table Aesica Product benchmarking

    • Table Aesica Strategic initiatives

    • Table Aesica SWOT analysis

    • Table Lonza Profiles

    • Table Lonza Production, Value, Price, Gross Margin 2014-2019

    • Table Lonza Product benchmarking

    • Table Lonza Strategic initiatives

    • Table Lonza SWOT analysis

    • Table Boehringer Ingelheim Profiles

    • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

    • Table Boehringer Ingelheim Product benchmarking

    • Table Boehringer Ingelheim Strategic initiatives

    • Table Boehringer Ingelheim SWOT analysis

    • Table Catalent Profiles

    • Table Catalent Production, Value, Price, Gross Margin 2014-2019

    • Table Catalent Product benchmarking

    • Table Catalent Strategic initiatives

    • Table Catalent SWOT analysis

    • Table Vetter Profiles

    • Table Vetter Production, Value, Price, Gross Margin 2014-2019

    • Table Vetter Product benchmarking

    • Table Vetter Strategic initiatives

    • Table Vetter SWOT analysis

    • Table Nipro Corp Profiles

    • Table Nipro Corp Production, Value, Price, Gross Margin 2014-2019

    • Table Nipro Corp Product benchmarking

    • Table Nipro Corp Strategic initiatives

    • Table Nipro Corp SWOT analysis

    • Table AbbVie Profiles

    • Table AbbVie Production, Value, Price, Gross Margin 2014-2019

    • Table AbbVie Product benchmarking

    • Table AbbVie Strategic initiatives

    • Table AbbVie SWOT analysis

    • Table Piramal Healthcare Profiles

    • Table Piramal Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Piramal Healthcare Product benchmarking

    • Table Piramal Healthcare Strategic initiatives

    • Table Piramal Healthcare SWOT analysis

    • Table Aenova Profiles

    • Table Aenova Production, Value, Price, Gross Margin 2014-2019

    • Table Aenova Product benchmarking

    • Table Aenova Strategic initiatives

    • Table Aenova SWOT analysis

    • Table Fareva Holding Profiles

    • Table Fareva Holding Production, Value, Price, Gross Margin 2014-2019

    • Table Fareva Holding Product benchmarking

    • Table Fareva Holding Strategic initiatives

    • Table Fareva Holding SWOT analysis

    • Table DPx Profiles

    • Table DPx Production, Value, Price, Gross Margin 2014-2019

    • Table DPx Product benchmarking

    • Table DPx Strategic initiatives

    • Table DPx SWOT analysis

    • Table Dishman Profiles

    • Table Dishman Production, Value, Price, Gross Margin 2014-2019

    • Table Dishman Product benchmarking

    • Table Dishman Strategic initiatives

    • Table Dishman SWOT analysis

    • Table NextPharma Profiles

    • Table NextPharma Production, Value, Price, Gross Margin 2014-2019

    • Table NextPharma Product benchmarking

    • Table NextPharma Strategic initiatives

    • Table NextPharma SWOT analysis

    • Table Famar Profiles

    • Table Famar Production, Value, Price, Gross Margin 2014-2019

    • Table Famar Product benchmarking

    • Table Famar Strategic initiatives

    • Table Famar SWOT analysis

    • Table Jubilant Profiles

    • Table Jubilant Production, Value, Price, Gross Margin 2014-2019

    • Table Jubilant Product benchmarking

    • Table Jubilant Strategic initiatives

    • Table Jubilant SWOT analysis

    • Table Sopharma Profiles

    • Table Sopharma Production, Value, Price, Gross Margin 2014-2019

    • Table Sopharma Product benchmarking

    • Table Sopharma Strategic initiatives

    • Table Sopharma SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.